本周四(9月12日),生物科技巨头 Moderna, Inc. 盘初大跌超17%,截止发稿报65.41美元。
公司盘前宣布,预计2025年的营业收入将下调至25亿-35亿美元,同时由于新产品的推出,预计2026年至2028年的复合年增长率将超过25%。
而公司在上个月发布的2024年第二季度业绩指引中,预计2025年的营业收入将达到30亿-35亿美元。
此外,由于实施投资组合优先级排序和成本效率措施,公司将其研发支出从2024年预计的48亿美元降低到2027年的36亿-38亿美元,总计减少了约11亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.